Aspirin for Hepatocellular Carcinoma Prevention in MASLD: How Far Are We Ready to Proceed?
: Editorial on “Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis”

Yang-Hyun Baek

doi:10.3350/cmh.2025.1482

Articles

Page Path

Editorial

Aspirin for Hepatocellular Carcinoma Prevention in MASLD: How Far Are We Ready to Proceed? : Editorial on “Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis”

Yang-Hyun Baek

DOI: https://doi.org/10.3350/cmh.2025.1482 [Accepted]

Published online: January 9, 2026

Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea

Corresponding author: Yang-Hyun Baek, Tel: +82-51-240-2728, Fax: +82-51-240-2087,
Email: p100100@dau.ac.kr

Received: 29 December 2025 • Accepted: 5 January 2026

413 Views
35 Download
0 Crossref
0 Scopus

Full Article

Download PDF

Keywords: aspirin, hepatocellular carcinoma (HCC), metabolic dysfunction-associated steatotic liver disease (MASLD), prevention

Citations

Citations to this article as recorded by

Cite

CITE

export

Copy Download

Format

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Aspirin for Hepatocellular Carcinoma Prevention in MASLD: How Far Are We Ready to Proceed? : Editorial on “Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis”

DOI: https://doi.org/10.3350/cmh.2025.1482

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
bib — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Aspirin for Hepatocellular Carcinoma Prevention in MASLD: How Far Are We Ready to Proceed? : Editorial on “Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis”

DOI: https://doi.org/10.3350/cmh.2025.1482

Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis

Articles

Page Path

Aspirin for Hepatocellular Carcinoma Prevention in MASLD: How Far Are We Ready to Proceed? : Editorial on “Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis”

Full Article

Citations

CITE

Download Citation

Format:

Include:

Related articles

ABOUT

BROWSE ARTICLES

FOR CONTRIBUTORS